Mangoceuticals, Inc. (MGRX) Ownership
MGRX ownership summary
as of October 17, 2026- Institutions
- 5.4% of shares outstanding
- Insiders
- 17.61% of shares outstanding
- Shares outstanding
- 22.2M
- Float
- 15.8M shares available to trade
- Short interest
- 2.21% 439K shares short
- Days to cover
- 0.91 short interest down 15.8% vs prior month
- Institutions 5.40%
- Insiders 17.61%
- Other investors 76.99%
MGRX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Citadel Advisors Llc | 1.57% | 339K | $98,300 | +338,964 (0.0%) | June 30, 2026 |
| 2 | XTX Topco Ltd | 0.86% | 186K | $54,014 | +173,114 (+1,317.3%) | June 30, 2026 |
| 3 | Geode Capital Management, LLC | 0.72% | 156K | $45,310 | −38,239 (−19.7%) | June 30, 2026 |
| 4 | Ikarian Capital, LLC | 0.64% | 138K | $40,062 | — | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 0.57% | 123K | $35,682 | — | June 30, 2026 |
| 6 | Vanguard Fiduciary Trust Co | 0.27% | 57K | $16,577 | — | June 30, 2026 |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 0.18% | 38K | $11,148 | — | June 30, 2026 |
| 8 | Northern Trust Corp | 0.17% | 38K | $10,898 | — | June 30, 2026 |
| 9 | HRT FINANCIAL LLC | 0.17% | 36K | $10,441 | +36,003 (0.0%) | June 30, 2026 |
| 10 | Ackerman Capital Advisors, LLC | 0.16% | 34K | $10,005 | — | June 30, 2026 |
| 11 | ACT Advisors, LLC | 0.12% | 27K | $7,790 | +26,863 (0.0%) | June 30, 2026 |
| 12 | Sunbelt Securities | 0.06% | 12K | $3,480 | — | March 31, 2026 |
| 13 | The Goldman Sachs Group Inc | 0.05% | 12K | $3,361 | −168 (−1.4%) | June 30, 2026 |
| 14 | Csenge Advisory Group, LLC | 0.05% | 10K | $2,900 | — | June 30, 2026 |
| 15 | Mercer Global Advisors Inc. | 0.03% | 6,667 | $1,933 | +6,667 (0.0%) | June 30, 2026 |
| 16 | Fortitude Family Office LLC | 0.01% | 1,343 | $389 | — | June 30, 2026 |
| 17 | Morgan Stanley - Brokerage Accounts | <0.01% | 1,000 | $290 | — | June 30, 2026 |
| 18 | Tower Research Capital LLC | <0.01% | 783 | $227 | −2 (−0.3%) | June 30, 2026 |
| 19 | Barclays PLC | 0.00% | 5 | $1 | +5 (0.0%) | June 30, 2026 |
| 20 | Jane Street Group LLC | 0.00% | — | — | −72,746 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 6 holders added 582K shares and 4 cut 111K.
MGRX top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 2.72% | 587K | $170,235 | +542,617 (+1,222.1%) | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.35% | 76K | $22,076 | −409 (−0.5%) | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.07% | 14K | $4,187 | — | August 31, 2026 |
| 4 | Fidelity Total Market Index | 0.06% | 13K | $3,839 | +633 (+5.0%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
MGRX insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-15 | Eugene M Johnston | Sell | $1.17 | 3,333 | $3,900 |
| 2025-12-09 | Eugene M Johnston | Sell | $1.20 | 5,000 | $6,000 |
| 2025-12-05 | Eugene M Johnston | Sell | $1.13 | 10,000 | $11,300 |
| 2025-11-19 | Alex P Hamilton | Sell | $1.22 | 125,000 | $152,500 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
MGRX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns MGRX
Institutional investors own 5.4% of Mangoceuticals's shares and insiders 17.61%. The largest holder is Citadel Advisors Llc with 1.57% of the shares (339K), as of June 30, 2026. Among the top 20 institutions, 6 added shares and 4 reduced their stake in the latest filings. Short interest is 2.21% of the float, or 0.91 days of average trading volume. The share count rose 1,492.5% since 2021.
Related: MGRX key metrics. See the MGRX stock overview for the latest quote and news.
MGRX ownership FAQ
Who owns the most Mangoceuticals stock?
The largest shareholders of Mangoceuticals are Citadel Advisors Llc (1.57%), XTX Topco Ltd (0.86%), Geode Capital Management, LLC (0.72%), Ikarian Capital, LLC (0.64%), Vanguard Capital Management, LLC (0.57%).
What percentage of Mangoceuticals is owned by institutions?
Institutions hold 5.4% of Mangoceuticals's shares outstanding; insiders hold 17.61%.
Which funds own Mangoceuticals?
The largest fund holders of Mangoceuticals are Fidelity Nasdaq Composite Index (2.72%), Fidelity Extended Market Index (0.35%), Fidelity Series Total Market Index (0.07%), Fidelity Total Market Index (0.06%).
What is Mangoceuticals's short interest?
439K shares of Mangoceuticals were sold short, 2.21% of the float; at the average daily volume it would take 0.91 days to cover.
Are insiders buying or selling Mangoceuticals?
Of the latest 4 reported insider transactions in Mangoceuticals (since November 19, 2025), 0 were purchases and 4 were sales.
How many shares of Mangoceuticals are outstanding?
Mangoceuticals has 22.2M shares outstanding, of which 15.8M are in the public float.